HAIFA, Israel, June 13, 2018 /PRNewswire/ -- Elbit
Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems")
announced today that it's subsidiary, Beyeonics Surgical Ltd.
("Beyeonics"), concluded a first round of funding raising a
$11.5 million investment from leading
investment groups including an international
corporation. Beyeonics develops innovative
surgeon-centered visualization technologies that improves the
surgeon's efficiency and substantially enhances patient safety and
surgical outcomes.
Beyeonics' first clinically tested system - Clarity™ Bionic
Visualization Platform – has a proven track record of providing
surgeons with Augmented/Virtual Reality vision capabilities that
replace surgical microscopes while allowing real-time integration
of an unlimited amount of data. The Clarity platform is comprised
of a Transparent Head Wearable Display that utilizes unique Elbit
Systems' displays technology, 3D Ultra-Resolution remote sensing
cameras, and a Processing Core that leverages Elbit Systems' image
processing know-how as well as fusion and analytical tools to
enable zero latency integration of information from multiple
digital sources. Undergoing clinical trials since 2016 the Clarity
platform has been successfully tested in more than 20 ophthalmic
surgeries both at the Tel Aviv Sourasky Medical Center and at
Retinal Consultants of Arizona.
Bezhalel (Butzi) Machlis, President and CEO of Elbit
Systems, commented: "Having completing this funding round on
the heels of Cyberbits' investment announcement, attests to the
commercial potential of our technologies. We are proud to have
spun-off a company that leverages some of our unique technologies
to materially enhance surgeons' capabilities in the operating room.
This investment will enable Beyeonics to expand product
development, to include additional surgical applications and
to accelerate commercialization."
About Beyeonic Surgical
Beyeonics Surgical technologies began operating in 2012, led by
a team of Elbit Systems senior engineers with a mission to
revolutionize the visualization and information presented during
surgery. Future products include visualization systems for other
surgical applications as well as solutions for spine surgery,
minimal invasive procedures, robotic surgery and use in
cardiovascular catheterization labs. Operating from Israel, Beyeonics is working in collaboration
with Prof. Anat Lowenstein the Head
of Ophthalmic Department and Prof. Adiel
Barak the Head of the Retina Department in Tel Aviv Sourasky
Medical Center and with Dr. Pravin
Dugel managing partner at Retinal Consultants of
Arizona.
About Elbit Systems
Elbit Systems Ltd. is an international high technology company
engaged in a wide range of defense, homeland security and
commercial programs throughout the world. The Company, which
includes Elbit Systems and its subsidiaries, operates in the areas
of aerospace, land and naval systems, command, control,
communications, computers, intelligence surveillance and
reconnaissance ("C4ISR"), unmanned aircraft systems, advanced
electro-optics, electro-optic space systems, EW suites, signal
intelligence systems, data links and communications systems, radios
and cyber-based systems. The Company also focuses on the
upgrading of existing platforms, developing new technologies for
defense, homeland security and commercial applications and
providing a range of support services, including training and
simulation systems.
For additional information, visit: www.elbitsystems.com, follow
us on Twitter or visit our official Youtube Channel.
This press release contains forward‑looking statements (within
the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21E of the Securities Exchange Act of 1934, as
amended) regarding Elbit Systems Ltd. and/or its subsidiaries
(collectively the Company), to the extent such statements do not
relate to historical or current fact. Forward-looking
statements are based on management's expectations, estimates,
projections and assumptions. Forward‑looking statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995, as amended. These
statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to
predict. Therefore, actual future results, performance and
trends may differ materially from these forward‑looking statements
due to a variety of factors, including, without limitation: scope
and length of customer contracts; governmental regulations and
approvals; changes in governmental budgeting priorities; general
market, political and economic conditions in the countries in which
the Company operates or sells, including Israel and the
United States among others; differences in anticipated and
actual program performance, including the ability to perform under
long-term fixed-price contracts; and the outcome of legal and/or
regulatory proceedings. The factors listed above are not
all-inclusive, and further information is contained in Elbit
Systems Ltd.'s latest annual report on Form 20-F, which is on file
with the U.S. Securities and Exchange Commission. All
forward‑looking statements speak only as of the date of this
release. The Company does not undertake to update its
forward-looking statements.
Elbit Systems Ltd., its logo, brand, product, service and
process names appearing in this Press Release are the trademarks or
service marks of Elbit Systems Ltd. or its affiliated
companies. All other brand, product, service and process
names appearing are the trademarks of their respective
holders. Reference to or use of a product, service or process
other than those of Elbit Systems Ltd. does not imply
recommendation, approval, affiliation or sponsorship of that
product, service or process by Elbit Systems Ltd. Nothing contained
herein shall be construed as conferring by implication, estoppel or
otherwise any license or right under any patent, copyright,
trademark or other intellectual property right of Elbit Systems
Ltd. or any third party, except as expressly granted herein.
Company
Contact:
Joseph Gaspar,
Executive VP & CFO
Tel:
+972-4-8316663
j.gaspar@elbitsystems.com
David Vaaknin,
VP, Head of Corporate Communications
Tel:
+972-77-2946691
David.Vaaknin@elbitsystems.com
Elbit Systems
Ltd.
|
IR
Contact:
Ehud
Helft
Kenny
Green
GK Investor
Relations
Tel:
1-646-201-9246
elbitsystems@gkir.com
|
View original
content:http://www.prnewswire.com/news-releases/elbit-systems-surgeon-centered-visualization-spin-off-beyeonics-raises-11-5-million-300665503.html
SOURCE Elbit Systems Ltd